179 related articles for article (PubMed ID: 31803539)
1.
Liu YY; Yang ZX; Ma LM; Wen XQ; Ji HL; Li K
PeerJ; 2019; 7():e8151. PubMed ID: 31803539
[TBL] [Abstract][Full Text] [Related]
2. Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and post-operative serum metabolomic fingerprint spectrum using
Yang Z; Liu Y; Ma L; Wen X; Ji H; Li K
Am J Transl Res; 2019; 11(2):819-831. PubMed ID: 30899382
[TBL] [Abstract][Full Text] [Related]
3. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.
Davis VW; Schiller DE; Eurich D; Sawyer MB
World J Surg Oncol; 2012 Dec; 10():271. PubMed ID: 23241138
[TBL] [Abstract][Full Text] [Related]
4. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
Gupta A; Gupta S; Mahdi AA
Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
[TBL] [Abstract][Full Text] [Related]
5. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
6. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
7. 1H-NMR based metabonomic profiling of human esophageal cancer tissue.
Wang L; Chen J; Chen L; Deng P; Bu Q; Xiang P; Li M; Lu W; Xu Y; Lin H; Wu T; Wang H; Hu J; Shao X; Cen X; Zhao YL
Mol Cancer; 2013 Apr; 12():25. PubMed ID: 23556477
[TBL] [Abstract][Full Text] [Related]
8. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
9. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
10. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
12. Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma.
Yu M; Wen W; Yi X; Zhu W; Aa J; Wang G
Front Oncol; 2022; 12():829350. PubMed ID: 35198450
[TBL] [Abstract][Full Text] [Related]
13.
Ouyang T; Ma C; Zhao Y; Ye W; Zhao J; Cai R; Zhang H; Zheng P; Lin Y
Front Oncol; 2023; 13():1082841. PubMed ID: 36756157
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the relationship of refractory gout between potential biomarkers and diet structure and lifestyle based on
Weidong L; Liuting C; Xiangcong C; Jianhong P; Xueying Y
J Orthop Surg Res; 2024 Jan; 19(1):78. PubMed ID: 38243298
[TBL] [Abstract][Full Text] [Related]
15. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between sepsis survivors and sepsis non-survivors through blood serum metabolomics: A proton nuclear magnetic resonance spectroscopy (NMR) study.
Naveen Kumar MS; Gupta G; Kumar V; Jagannathan NR; Sinha S; Mewar S; Kumar P
Magn Reson Imaging; 2022 Jun; 89():49-57. PubMed ID: 35176448
[TBL] [Abstract][Full Text] [Related]
17. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
18. (1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
Cocco E; Murgia F; Lorefice L; Barberini L; Poddighe S; Frau J; Fenu G; Coghe G; Murru MR; Murru R; Del Carratore F; Atzori L; Marrosu MG
Neurol Neuroimmunol Neuroinflamm; 2016 Feb; 3(1):e185. PubMed ID: 26740964
[TBL] [Abstract][Full Text] [Related]
19. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
20. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
